Literature DB >> 3417532

Clinical significance of aerobic bacterial flora of the uterus, vagina, vestibule, and clitoral fossa of clinically normal mares.

K Hinrichs1, M R Cummings, P L Sertich, R M Kenney.   

Abstract

Swab specimens for bacterial culture were obtained from the uterus, vagina, vestibule, and clitoral fossa of 48 mares that had normal reproductive tracts, no history of reproductive problems, and no inflammation on evaluation of endometrial biopsy. The mares were predominantly Thoroughbred and Standardbred. Swab specimens of the vagina were obtained through a sterile speculum; swab specimens of the uterus were obtained by use of a double-guarded, occluded culture instrument. Fifteen (31%) of the uterine swab specimens and 20 (42%) of the vaginal swab specimens yielded growth on aerobic culture; however, only 2 (4%) of the uterine swab specimens and 4 (8%) of the vaginal swab specimens yielded growth of more than 10 colonies. In contrast, 21 (44%) of the vestibular swab specimens and 45 (94%) of the clitoral fossa swab specimens had moderate (greater than 10 colonies in 1 quadrant) to heavy (colonies in 2 or 3 quadrants) growth of organisms on culture. Of organisms considered to be potential pathogens, Streptococcus zooepidemicus and Escherichia coli were found on bacteriologic culture of several clitoral fossa swab specimens and of some vestibular swab specimens. We did not isolate any potential pathogens from uterine or vaginal swab specimens. It appears that 1 to 10 colonies of nonpathogenic organisms could be recovered from the uterus in a substantial number of clinically normal mares even when double-guarded swabbing techniques are used, and we suggest that prebreeding culture requirements be modified to reflect this. Also, our findings indicate that the vulvovaginal fold, rather than the cervix, might be the major barrier to ascending bacterial contamination of the reproductive tract.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1988        PMID: 3417532

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  7 in total

1.  Bacterial isolates from equine infections in western Canada (1998-2003).

Authors:  Chris Clark; Sarah Greenwood; Joe O Boison; Manuel Chirino-Trejo; Patricia M Dowling
Journal:  Can Vet J       Date:  2008-02       Impact factor: 1.008

2.  Streptomycin-resistant Escherichia coli as a marker of vulvovestibular contamination of endometrial culture swabs in the mare.

Authors:  R O Waelchli; L Corboz; M Doebeli
Journal:  Can J Vet Res       Date:  1992-10       Impact factor: 1.310

3.  Inflammatory responses to induced infectious endometritis in mares resistant or susceptible to persistent endometritis.

Authors:  Mette Christoffersen; Elizabeth Woodward; Anders M Bojesen; Stine Jacobsen; Morten R Petersen; Mats Ht Troedsson; Henrik Lehn-Jensen
Journal:  BMC Vet Res       Date:  2012-03-29       Impact factor: 2.741

4.  Microbial Prevalence and Antimicrobial Sensitivity in Equine Endometritis in Field Conditions.

Authors:  María Luisa Díaz-Bertrana; Stefan Deleuze; Lidia Pitti Rios; Marc Yeste; Inmaculada Morales Fariña; Maria Montserrat Rivera Del Alamo
Journal:  Animals (Basel)       Date:  2021-05-20       Impact factor: 2.752

5.  Streptococcus equi subsp. zooepidemicus isolates from equine infectious endometritis belong to a distinct genetic group.

Authors:  Camilla Dooleweerdt Rasmussen; Maria Mathilde Haugaard; Morten Roenn Petersen; Jesper Møller Nielsen; Hanne Gervi Pedersen; Anders Miki Bojesen
Journal:  Vet Res       Date:  2013-04-18       Impact factor: 3.683

6.  Uterine microbiology and antimicrobial susceptibility in isolated bacteria from mares with fertility problems.

Authors:  A Albihn; V Båverud; U Magnusson
Journal:  Acta Vet Scand       Date:  2003       Impact factor: 1.695

7.  Model of Chronic Equine Endometritis Involving a Pseudomonas aeruginosa Biofilm.

Authors:  Ryan A Ferris; Patrick M McCue; Grace I Borlee; Kristina E Glapa; Kevin H Martin; Mihnea R Mangalea; Margo L Hennet; Lisa M Wolfe; Corey D Broeckling; Bradley R Borlee
Journal:  Infect Immun       Date:  2017-11-17       Impact factor: 3.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.